(FCX) Freeport-McMoran Copper - Overview
Stock: Copper, Gold, Molybdenum, Silver
| Risk 5d forecast | |
|---|---|
| Volatility | 40.4% |
| Relative Tail Risk | -3.88% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.20 |
| Alpha | 49.18 |
| Character TTM | |
|---|---|
| Beta | 1.634 |
| Beta Downside | 1.742 |
| Drawdowns 3y | |
|---|---|
| Max DD | 46.34% |
| CAGR/Max DD | 0.41 |
EPS (Earnings per Share)
Revenue
Description: FCX Freeport-McMoran Copper January 29, 2026
Freeport-McMoRan Inc. (NYSE:FCX) is a diversified mining company operating across North America, South America, and Indonesia, with primary exposure to copper, gold, molybdenum, and silver. Its asset portfolio includes the world-class Grasberg district (Indonesia), major U.S. operations such as Morenci, Bagdad, and Sierrita, and South American mines at Cerro Verde (Peru) and El Abra (Chile). The firm, incorporated in 1987 and headquartered in Phoenix, Arizona, rebranded from Freeport-McMoRan Copper & Gold Inc. in July 2014.
Recent performance metrics (FY 2025): copper production of ≈ 1.5 million tonnes (up 3 % YoY), free cash flow of $2.2 billion, and a net debt level of $10 billion, yielding a debt-to-EBITDA ratio of ≈ 2.5×. The company reported a quarterly dividend of $0.84 per share (≈ 2.8 % yield) and announced a 2026 capex budget of $2.5 billion focused on expanding the Morenci and Cerro Verde operations.
Key drivers for FCX’s outlook include: (1) sustained copper price strength-averaging $4.30 per lb in Q4 2025, supported by supply constraints and rising demand; (2) macro-level demand growth from renewable-energy infrastructure and electric-vehicle production, projected to lift global copper consumption at a 4 % CAGR through 2030; and (3) geopolitical risk in Indonesia’s mining policy, which introduces execution uncertainty for the Grasberg expansion.
For a deeper, data-rich assessment of FCX’s valuation dynamics, a quick look at the ValueRay platform can help surface comparable peer multiples and scenario-based cash-flow models.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 2.20b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 5.36 > 1.0 |
| NWC/Revenue: 30.19% < 20% (prev 31.03%; Δ -0.84% < -1%) |
| CFO/TA 0.10 > 3% & CFO 5.61b > Net Income 2.20b |
| Net Debt (8.15b) to EBITDA (8.76b): 0.93 < 3 |
| Current Ratio: 2.29 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.44b) vs 12m ago -0.14% < -2% |
| Gross Margin: 26.98% > 18% (prev 0.29%; Δ 2669 % > 0.5%) |
| Asset Turnover: 45.55% > 50% (prev 45.84%; Δ -0.28% > 0%) |
| Interest Coverage Ratio: 17.65 > 6 (EBITDA TTM 8.76b / Interest Expense TTM 369.0m) |
Altman Z'' 1.78
| A: 0.13 (Total Current Assets 13.79b - Total Current Liabilities 6.02b) / Total Assets 58.17b |
| B: 0.02 (Retained Earnings 1.39b / Total Assets 58.17b) |
| C: 0.12 (EBIT TTM 6.51b / Avg Total Assets 56.51b) |
| D: 0.05 (Book Value of Equity 1.24b / Total Liabilities 27.40b) |
| Altman-Z'' Score: 1.78 = BBB |
Beneish M -2.58
| DSRI: 1.44 (Receivables 1.68b/1.14b, Revenue 25.74b/25.14b) |
| GMI: 1.06 (GM 26.98% / 28.59%) |
| AQI: 1.13 (AQ_t 0.06 / AQ_t-1 0.06) |
| SGI: 1.02 (Revenue 25.74b / 25.14b) |
| TATA: -0.06 (NI 2.20b - CFO 5.61b) / TA 58.17b) |
| Beneish M-Score: -2.58 (Cap -4..+1) = A |
What is the price of FCX shares?
Over the past week, the price has changed by +2.39%, over one month by +7.11%, over three months by +62.76% and over the past year by +67.44%.
Is FCX a buy, sell or hold?
- StrongBuy: 8
- Buy: 5
- Hold: 6
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the FCX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 64 | -0.5% |
| Analysts Target Price | 64 | -0.5% |
FCX Fundamental Data Overview February 21, 2026
P/E Forward = 25.641
P/S = 3.467
P/B = 4.7745
P/EG = 4.1369
Revenue TTM = 25.74b USD
EBIT TTM = 6.51b USD
EBITDA TTM = 8.76b USD
Long Term Debt = 9.92b USD (from longTermDebt, last quarter)
Short Term Debt = 569.0m USD (from shortTermDebt, last quarter)
Debt = 11.50b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.15b USD (from netDebt column, last quarter)
Enterprise Value = 97.52b USD (89.85b + Debt 11.50b - CCE 3.82b)
Interest Coverage Ratio = 17.65 (Ebit TTM 6.51b / Interest Expense TTM 369.0m)
EV/FCF = 17.38x (Enterprise Value 97.52b / FCF TTM 5.61b)
FCF Yield = 5.75% (FCF TTM 5.61b / Enterprise Value 97.52b)
FCF Margin = 21.79% (FCF TTM 5.61b / Revenue TTM 25.74b)
Net Margin = 8.54% (Net Income TTM 2.20b / Revenue TTM 25.74b)
Gross Margin = 26.98% ((Revenue TTM 25.74b - Cost of Revenue TTM 18.80b) / Revenue TTM)
Gross Margin QoQ = 18.05% (prev 29.93%)
Tobins Q-Ratio = 1.68 (Enterprise Value 97.52b / Total Assets 58.17b)
Interest Expense / Debt = 0.96% (Interest Expense 110.0m / Debt 11.50b)
Taxrate = 26.37% (202.0m / 766.0m)
NOPAT = 4.80b (EBIT 6.51b * (1 - 26.37%))
Current Ratio = 2.29 (Total Current Assets 13.79b / Total Current Liabilities 6.02b)
Debt / Equity = 0.61 (Debt 11.50b / totalStockholderEquity, last quarter 18.90b)
Debt / EBITDA = 0.93 (Net Debt 8.15b / EBITDA 8.76b)
Debt / FCF = 1.45 (Net Debt 8.15b / FCF TTM 5.61b)
Total Stockholder Equity = 18.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.89% (Net Income 2.20b / Total Assets 58.17b)
RoE = 11.97% (Net Income TTM 2.20b / Total Stockholder Equity 18.37b)
RoCE = 23.02% (EBIT 6.51b / Capital Employed (Equity 18.37b + L.T.Debt 9.92b))
RoIC = 17.31% (NOPAT 4.80b / Invested Capital 27.70b)
WACC = 10.66% (E(89.85b)/V(101.35b) * Re(11.94%) + D(11.50b)/V(101.35b) * Rd(0.96%) * (1-Tc(0.26)))
Discount Rate = 11.94% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.03%
[DCF Debug] Terminal Value 73.10% ; FCFF base≈4.31b ; Y1≈5.31b ; Y5≈9.05b
Fair Price DCF = 63.15 (EV 98.82b - Net Debt 8.15b = Equity 90.67b / Shares 1.44b; r=10.66% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -31.37 | EPS CAGR: -19.70% | SUE: 4.0 | # QB: 3
Revenue Correlation: 38.24 | Revenue CAGR: -3.21% | SUE: 0.53 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.48 | Chg30d=-0.033 | Revisions Net=+0 | Analysts=8
EPS current Year (2026-12-31): EPS=2.79 | Chg30d=+0.272 | Revisions Net=+6 | Growth EPS=+57.4% | Growth Revenue=+11.9%
EPS next Year (2027-12-31): EPS=3.49 | Chg30d=+0.377 | Revisions Net=+4 | Growth EPS=+25.1% | Growth Revenue=+14.9%